Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis UTHR

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History UTHR

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth UTHR

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin UTHR

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income UTHR

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM UTHR

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio UTHR

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

United Therapeutics Corporation UTHR

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself UTHR

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 18.25
Forward PE 15.43
Enterprise Value Revenue 5.61
Price Sales TTM 6.95
Enterprise Value EBITDA 9.90
Price Book MRQ 3.14

United Therapeutics Corporation Dividends: – Yield, History, Payment Schedule

UTHR
Current price
484.10 USD +3.47 USD (+0.72%)
Last closed 480.96 USD
ISIN US91307C1027
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 21 752 023 040 USD
Yield for 12 month +29.31 %
1Y
3Y
5Y
10Y
15Y
UTHR
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+2 877 400 000 USD

Last Year

+2 327 500 000 USD

Current Quarter

+799 500 000 USD

Last Quarter

+798 600 000 USD

Current Year

+2 567 700 000 USD

Last Year

+2 070 000 000 USD

Current Quarter

+698 600 000 USD

Last Quarter

+711 000 000 USD
EBITDA 1 604 099 968 USD
Operating Margin TTM 48.69 %
Price to Earnings 18.25
Return On Assets TTM 13.14 %
PEG Ratio 1.43
Return On Equity TTM 20.04 %
Wall Street Target Price 518.25 USD
Revenue TTM 3 128 399 872 USD
Book Value 153.61 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 6.80 %
Dividend Yield
Gross Profit TTM 2 771 500 032 USD
Earnings per share 26.36 USD
Diluted Eps TTM 26.36 USD
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 12.10 %
Profit Margin 40.65 %

Technical Indicators UTHR

For 52 Weeks

266.98 USD 492.62 USD
50 Day MA 448.67 USD
Shares Short Prior Month 1 683 024
200 Day MA 348.10 USD
Short Ratio 2.88
Shares Short 1 650 438
Short Percent 5.11 %